Upcoming events on BIONTECH SE |
|
05/23/22 | | Berenberg Bank USA Conference |
06/01/22 | 08:00am | | Annual General Meeting |
06/03/22 | 09:00am | | Bernstein Strategic Decisions Conference |
06/29/22 | | Capital Markets Day |
08/08/22 | | Interim 2022 Earnings Release |
08/08/22 | 08:00am | | Interim 2022 Earnings Call |
11/07/22 | | Q3 2022 Earnings Release |
11/07/22 | 08:00am | | Q3 2022 Earnings Call |
03/29/23 | | FY 2022 Earnings Release (Projected) |
05/08/23 | | Q1 2023 Earnings Release (Projected) |
|
Past events on BIONTECH SE |
|
05/09/22 | 08:00am | | Q1 2022 Earnings Call |
05/09/22 | 06:01am | | Q1 2022 Earnings Release |
04/26/22 | | Jefferies Biotech on the Bay Summit |
04/20/22 | | Kempen Life Sciences Conference |
04/06/22 | 10:00am | | JP Morgan Napa Valley Biotech Forum |
03/30/22 | 08:00am | | FY 2021 Earnings Call |
03/30/22 | 06:00am | | FY 2021 Earnings Release |
03/09/22 | 11:10am | | Cowen Health Care Conference |
02/16/22 | 08:40am | | SVB Leerink Global Healthcare Conference |
02/16/22 | 08:30am | | Business Update Call |
|
Past dividends on BIONTECH SE |
|
- No events available -
|
|
Fiscal Period : December | 2019 | 2020 | 2021 | 2022 |
Sales M € |
Released Forecast Spread | 109 110 -1,6% | 482 432 12% | 18 977 17 212 10% | 16 941 |
Operating income (EBITDA) M € |
Released Forecast Spread | -148 -145 -1,9% | -43,7 -287 85% | 15 359 13 568 13% | 12 021 |
Operating profit (EBIT) M € |
Released Forecast Spread | -182 -167 -8,7% | -82,4 -306 73% | 15 284 13 364 14% | 11 877 |
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -179 -158 -14% | -146 -325 55% | 15 046 13 109 15% | 12 889 |
Net income M € |
Released Forecast Spread | -179 -157 -14% | 15,2 -336 105% | 10 293 9 140 13% | 9 121 |
EPS € |
Released Forecast Spread | -0,85 -0,74 -15% | 0,06 -1,44 104% | 39,6 36,2 9,4% | 34,9 | Announcement Date | 03/31/2020 | 03/30/2021 | 03/30/2022 | - |
|
|
Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales M € |
Released Forecast Spread | 27,7 24,5 13% | 41,8 41,5 0,58% | 67,5 51,7 30% | 345 190 82% | 2 048 1 793 14% | 5 309 3 274 62% | 6 087 5 020 21% | 5 533 3 918 41% | 6 375 4 496 42% | 4 304 | 3 576 | 3 501 | 1 332 |
|
Operating income (EBITDA) M € |
Released Forecast Spread | -50,7 -55,0 7,8% | -72,1 -50,0 -44% | -178 -72,4 -145% | 257 -199 229% | 1 675 1 385 21% | 4 215 2 528 67% | 4 743 3 000 58% | 4 726 2 750 72% |
|
|
|
|
|
|
Operating profit (EBIT) M € |
Released Forecast Spread | -59,3 -59,1 -0,38% | -80,9 -74,8 -8,1% | -186 -92,6 -101% | 244 -24,6 1 091% | 1 662 986 69% | 4 198 2 554 64% | 4 724 3 968 19% | 4 700 2 817 67% | 4 753 3 449 38% | 3 043 | 2 267 | 2 187 | 511 |
|
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -53,4 -51,1 -4,5% | -90,5 -61,5 -47% | -208 -73,6 -182% | 206 -57,2 460% | 1 642 1 379 19% | 4 023 2 637 53% | 4 667 3 309 41% | 4 714 2 475 90% | 5 018 3 337 50% | 2 892 | 2 522 | 2 449 |
|
|
Net income M € |
Released Forecast Spread | -53,4 -57,2 6,6% | -88,3 -58,9 -50% | -210 -90,0 -133% | 367 -59,0 722% | 1 128 778 45% | 2 787 1 784 56% | 3 211 2 671 20% | 3 166 1 893 67% | 3 699 2 484 49% | 1 946 | 1 278 | 2 031 |
|
|
EPS € |
Released Forecast Spread | -0,24 -0,25 4,7% | -0,38 -0,32 -20% | -0,88 -0,41 -114% | 1,57 -0,16 1 111% | 4,39 3,09 42% | 10,8 6,94 55% | 12,4 10,4 19% | 12,2 7,55 61% | 14,2 8,90 60% | 7,35 | 7,34 | 7,02 | 3,06 | 2,31 | Announcement Date | 05/12/2020 | 08/11/2020 | 11/10/2020 | 03/30/2021 | 05/10/2021 | 08/09/2021 | 11/09/2021 | 03/30/2022 | 05/09/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for BIONTECH SE |
|
|
|
Past sector events for BIONTECH SE |
|
|
|
|
|
|
Pfizer's $11.6 billion Biohaven buy could spark more biotech deals |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|